nach oben

Erschienen in:

01.06.2014 | Original Article

Practices and opinions regarding HPV vaccination among French general practitioners: evaluation through two cross-sectional studies in 2007 and 2010

verfasst von: Christine Lasset, Julie Kalecinski, Véronique Régnier, Giovanna Barone, Yann Leocmach, Philippe Vanhems, Franck Chauvin, Delphine Lutringer-Magnin

Erschienen in: International Journal of Public Health | Ausgabe 3/2014

Einloggen, um Zugang zu erhalten

Abstract

Objectives

To use both quantitative and qualitative methods to investigate the evolution of practices and opinions regarding human papillomavirus (HPV) vaccination among French general practitioners.

Methods

A cross-sectional study (self-questionnaires) was performed in 2007 and repeated in 2010 among 271 general practitioners. Semi-structured interviews were conducted on 27 voluntary participants by a sociologist and analyzed according to content analysis.

Results

Acceptability of HPV vaccination had increased from 2007 to 2010 (79.9 vs. 87.1 %, respectively), just as the practice of HPV vaccination among 14-year-old girls (19.0 vs. 49.1 %, respectively). Though about 60 % reported complications associated with HPV vaccination, irrespective of year, the types of difficulties have varied: difficulties related to “questions asked by patients” had decreased, though concerns about side effects had remained stable. During interviews, difficulties related to “the reason for medical consultation” and “the target age” were often associated with addressing the issue of sexuality, especially when the parents were present.

Conclusions

Although the high level of acceptability of HPV vaccination among general practitioners, which increased from 2007 to 2010, there remain difficulties in addressing this practice.

Agius PA, Pitts MK, Smith AM, Mitchell A (2010) Human papillomavirus and cervical cancer: Gardasil vaccination status and knowledge amongst a nationally representative sample of Australian secondary school students. Vaccine 28:4416–4422PubMedCrossRef

Brotherton JM, Fridman M, May CL, Chappell G, Saville AM, Gertig DM (2011) Early effect of the HPV vaccination programme on cervical abnormalities in Victoria, Australia: an ecological study. Lancet 377:2085–2092PubMedCrossRef

Creswell JW, Plano Clark VL (2007) Designing and conducting mixed methods research. Sage Publications, Thousand Oaks

Daley MF, Crane LA, Markowitz LE, Black SR, Beaty BL, Barrow J et al (2010) Human papillomavirus vaccination practices: a survey of US physicians 18 months after licensure. Pediatrics 126:425–433PubMedCrossRef

Darden PM, Thompson DM, Roberts JR, Hale JJ, Pope C, Naifeh M, et al. (2013) Reasons for not vaccinating adolescents: national immunization survey of teens, 2008–2010. Pediatrics 131:645–651

De Carvalho NS, Teixeira LM, Pradel EM, Gabardo J, Joly C, Urbanetz AA (2009) Vaccinating against HPV: physicians’ and medical students’ point of view. Vaccine 27:2637–2640PubMedCrossRef

Demarteau N, Detournay B, Tehard B, El Hasnaoui A, Standaert B (2011) A generally applicable cost-effectiveness model for the evaluation of vaccines against cervical cancer. Int J Public Health 56:153–162PubMedCentralPubMedCrossRef

Donovan B, Franklin N, Guy R, Grulich AE, Regan DG, Ali H et al (2011) Quadrivalent human papillomavirus vaccination and trends in genital warts in Australia: analysis of national sentinel surveillance data. Lancet Infect Dis 11:39–44PubMedCrossRef

Dorleans F, Giambi C, Dematte L, Cotter S, Stefanoff P, Mereckiene J, et al. (2010) The current state of introduction of human papillomavirus vaccination into national immunisation schedules in Europe: first results of the VENICE2 2010 survey. Euro Surv 15(47)

European Centre for Disease prevention and Control (2012) ECDC guidance, introduction of HPV vaccines in European Union countries––an update. pp 19

Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM (2011) Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer 127:2893–2917CrossRef

Forster AS, Marlow LA, Wardle J, Stephenson J, Waller J (2010) Understanding adolescents’ intentions to have the HPV vaccine. Vaccine 28:1673–1676PubMedCrossRef

Haesebaert J, Lutringer-Magnin D, Kalecinski J, Barone G, Jacquard AC, Régnier V et al (2012) French women’s knowledge of and attitudes towards cervical cancer prevention and the acceptability of HPV vaccination among those with 14–18 year old daughters: a quantitative–qualitative study. BMC Public Health 12:1034PubMedCentralPubMedCrossRef

Haut Conseil de la santé publique (2011). Avis relatif au vaccin Gardasil^® et à la stratégie de prévention globale des cancers du col de l’utérus à la vaccination contre les infections à papillomavirus humains des jeunes filles âgées de 14 à 23 ans (HPV vaccination recommendations from the « Haut Conseil de la santé publique » in France). Available: http://www.hcsp.fr/docspdf/avisrapports/hcspa20111021_gardasil.pdf http://www.fncgm.com/images/Actualites_medicales_scientifiques/vaccin_pap_hcsp_12-2010.pdf. Accessed 22 February 2013

Hopkins TG, Wood NJ, West RM, Darling JC (2009) UK health professionals’ attitudes and knowledge regarding Human Papillomavirus (HPV) vaccination: a West Yorkshire Study. J Paediatr Child Health 45:652–655PubMedCrossRef

Institut de Veille Sanitaire (2012) Projection de l’incidence et de la mortalité par cancer en France en 2011: col de l’utérus. Available:http://invs.sante.fr. Accessed 30 January 2013

Jeannot E, Sudre P, Chastonay P (2012) HPV vaccination coverage within 3 years of program launching (2008–2011) at Geneva State, Switzerland. Int J Public Health 57:629–632PubMedCrossRef

Jensen ME, Hartenbach E, McElroy JA, Faerber A, Havighurst T, Kim KM et al (2009) Brief report: measuring the attitudes of health care professionals in Dane County toward adolescent immunization with HPV vaccine. WMJ 108:203–205PubMedCentralPubMed

Jim CC, Lee JW, Groom AV, Espey DK, Saraiya M, Holve S et al (2012) Human papillomavirus vaccination practices among providers in Indian health service, tribal and urban Indian healthcare facilities. J Womens Health 21:372–378CrossRef

Kahn JA, Cooper HP, Vadaparampil ST, Pence BC, Weinberg AD, LoCoco SJ et al (2009) Human papillomavirus vaccine recommendations and agreement with mandated human papillomavirus vaccination for 11-to-12-year-old girls: a statewide survey of Texas physicians. Cancer Epidemiol Biomarkers Prev 18:2325–2332PubMedCrossRef

Kempe A, Daley MF, McCauley MM, Crane LA, Suh CA, Kennedy AM et al (2011) Prevalence of parental concerns about childhood vaccines: the experience of primary care physicians. Am J Prev Med 40:548–555PubMedCrossRef

Ko EM, Missmer S, Johnson NR (2010) Physician attitudes and practice toward human papillomavirus vaccination. J Low Genit Tract Dis 14:339–345PubMedCrossRef

Krupp K, Marlow LA, Kielmann K, Doddaiah N, Mysore S, Reingold AL et al (2010) Factors associated with intention-to-recommend human papillomavirus vaccination among physicians in Mysore, India. J Adolesc Health 46:379–384PubMedCrossRef

Leib S, Liberatos P, Edwards K (2011) Pediatricians’ experience with and response to parental vaccine safety concerns and vaccine refusals: a survey of Connecticut pediatricians. Public Health Rep 126(Suppl 2):13–23PubMedCentralPubMed

Lu B, Kumar A, Castellsagué X, Giuliano AR (2011) Efficacy and safety of prophylactic vaccines against cervical HPV infection and diseases among women: a systematic review and meta-analysis. BMC Infect Dis 11:13PubMedCentralPubMedCrossRef

Lutringer-Magnin D, Kalecinski J, Barone G, Leocmach Y, Regnier V, Jacquard AC et al (2011) Human papillomavirus (HPV) vaccination: perception and practice among French general practitioners in the year since licensing. Vaccine 29:5322–5328PubMedCrossRef

Marlow LA, Wardle J, Forster AS, Waller J (2009) Ethnic differences in human papillomavirus awareness and vaccine acceptability. J Epidemiol Commun Health 63:1010–1015CrossRef

McCave EL (2010) Influential factors in HPV vaccination uptake among providers in four states. J Commun Health 35:645–652CrossRef

Miles MB, Huberman MA (2003) Analyse des données qualitatives. De Boeck, Bruxelles, p 2

Munoz N, Bosch FX, de Sanjose S, Herrero R, Castellsague X, Shah KV et al (2003) Epidemiologic classification of human papillomavirus types associated with cervical cancer. N Engl J Med 348:518–527PubMedCrossRef

Pélissier G, Bastides F (2008) Vaccination anti-HPV dans le cadre de la prévention du cancer du col de l’utérus en médecine générale. Rev Prat 58:25–31PubMed

Perkins RB, Clark JA (2012) What affects human papillomavirus vaccination rates? A qualitative analysis of providers’ perceptions. Womens Health Issues 22:e378–e379CrossRef

Piana L, Noel G, Uters M, Laporte R, Minodier P (2009) Standpoint and practice concerning the human Papillomavirus vaccine among French family physicians. Med Mal Infect 39:789–797PubMedCrossRef

Post RE, Carek PJ, Mainous Iii AG, Diaz VA, Johnson SP (2013) Factors affecting HPV vaccine use among recent family medicine residency graduates. Fam Med 45:90–94PubMed

Remes P, Selestine V, Changalucha J, Ross DA, Wight D, de Sanjosé S et al (2012) A qualitative study of HPV vaccine acceptability among health workers, teachers, parents, female pupils, and religious leaders in northwest Tanzania. Vaccine 30:5363–5367PubMedCentralPubMedCrossRef

Schnatz PF, Humphrey K, O’Sullivan DM (2010) Assessment of the perceptions and administration of the human papillomavirus vaccine. Low Genit Tract Dis 14:103–107CrossRef

Trim K, Nagji N, Elit L, Roy K (2012) Parental knowledge, attitudes, and behaviours towards human papillomavirus vaccination for their children: a systematic review from 2001 to 2011. Obstet Gynecol Int 2012:921236PubMedCentralPubMedCrossRef

Vadaparampil ST, Kahn JA, Salmon D, Lee JH, Quinn GP, Roetzheim R et al (2011) Missed clinical opportunities: provider recommendations for HPV vaccination for 11–12 years old girls are limited. Vaccine 29:8634–8641PubMedCentralPubMedCrossRef

Wong LP (2011) Issues surrounding HPV vaccine delivery in a multi-ethnic country in Asia: the physician’s perspective. J Commun Health 36:14–22CrossRef

Young JL, Bernheim RG, Korte JE, Stoler MH, Guterbock TM, Rice LW (2011) Human papillomavirus vaccination recommendation may be linked to reimbursement: a survey of Virginia family practitioners and gynecologists. J Pediatr Adolesc Gynecol 24:380–385PubMedCrossRef

Titel: Practices and opinions regarding HPV vaccination among French general practitioners: evaluation through two cross-sectional studies in 2007 and 2010
verfasst von: Christine Lasset
Julie Kalecinski
Véronique Régnier
Giovanna Barone
Yann Leocmach
Philippe Vanhems
Franck Chauvin
Delphine Lutringer-Magnin
Publikationsdatum: 01.06.2014
Verlag: Springer Basel
Erschienen in: International Journal of Public Health / Ausgabe 3/2014
Print ISSN: 1661-8556
Elektronische ISSN: 1661-8564
DOI: https://doi.org/10.1007/s00038-014-0555-9

Springer Medizin

Abstract

Objectives

Methods

Results

Conclusions

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 3/2014

Individual- and area-level effects on mortality risk in Germany, both East and West, among male Germans aged 65+

Exploring subgroup effects by socioeconomic position of three effective school-based dietary interventions: the European TEENAGE project

Health inequalities and regional specific scarcity in primary care physicians: ethical issues and criteria

How much energy is locked in the USA? Alternative metrics for characterising the magnitude of overweight and obesity derived from BRFSS 2010 data

Calculating disability-adjusted life years to quantify burden of disease

Health conditions in regions of Eastern and Western Europe